ADH4 and hepatocellular carcinoma: As shown in Additional file 1: Table S13, ADH4 expression was found to be negatively correlated with the IC50 of 17-AAG, AZD6244, PD-0325901, AEW541, TAE684, Panobinostat, and RAF265 in HCC cell lines, indicating the positive association with HCC sensitivities to these anticancer drugs.